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Abstract: SUMO is a post-translational modifier critical for
cell cycle progression and genome stability that plays a role in
tumorigenesis, thus rendering SUMO-specific enzymes poten-
tial pharmacological targets. However, the systematic gener-
ation of tools for the activity profiling of SUMO-specific
enzymes has proven challenging. We developed a diversifiable
synthetic platform for SUMO-based probes by using a direct
linear synthesis method, which permits N- and C-terminal
labelling to incorporate dyes and reactive warheads, respec-
tively. In this manner, activity-based probes (ABPs) for
SUMO-1, SUMO-2, and SUMO-3-specific proteases were
generated and validated in cells using gel-based assays and
confocal microscopy. We further expanded our toolbox with
the synthesis of a K11-linked diSUMO-2 probe to study the
proteolytic cleavage of SUMO chains. Together, these ABPs
demonstrate the versatility and specificity of our synthetic
SUMO platform for in vitro and in vivo characterization of the
SUMO protease family.
Post-translational modifications (PTMs) are reversible
chemical additions to a protein following translation. Phos-
phorylation and ubiquitination are prominent examples of
important and well-studied PTMs that regulate a plethora of
cellular processes.[1] Similarly, SUMOylation is another PTM
that is known to apply to large number of proteins.[1, 2] Despite
the name small ubiquitin-like modifier (SUMO), ubiquitin
(Ub) and SUMO share less than 20 % amino acid sequence
identity, but they possess comparable three dimensional
structures.[3] Unlike Ub (8 kDa), SUMO proteins have an
N-terminal flexible extension, which makes them significantly
larger (11 kDa). SUMOylation is directed by an enzymatic
cascade analogous to ubiquitination and SUMO is generally
conjugated onto lysine residues of target proteins.[4] SUMO
has 3 active isoforms, SUMO-1, -2 and -3, with mature
SUMO-2 and -3 being virtually identical.[5] Importantly,
SUMO-1–3 themselves can be further modified by additional
PTMs, including acetylation, phosphorylation, methylation,
ubiquitination, or even SUMOylation, with the latter result-
ing in polySUMO chains.[6] SUMOylation can then be
removed by specific SUMO proteases, namely the cysteine
proteases USP-L1, the Sentrin-specific proteases (SENP1,
SENP2, SENP3, SENP5, SENP6, SENP7), and Desi-1 and
Desi-2, thus rendering this PTM reversible and dynamic.
SUMO proteases also mediate the maturation of SUMO
precursors.[7]
SUMO is mainly found in the nucleus and plays indis-
pensable roles in the DNA damage response, gene expression,
and cell-cycle progression. It has been established that many
tumours rely on a functional SUMO pathway, which makes
SUMO-related processes potential anti-cancer drug targets.[8]
However, the molecular mechanisms underlying the role of
SUMO modification in these processes remain poorly under-
stood, in part due to the slow development of activity-based
reagents.[9] In contrast, research in the ubiquitin field has
accelerated due to the convenient chemical synthesis of
ubiquitin,[10] which has given access to assay reagents and
probes[11–14] Therefore, a reliable route towards SUMO-based
conjugates is urgently needed to provide the reagents
required to visualize and understand the biology of reversible
SUMOylation.
SUMO conjugates have been prepared before by semi-
synthesis using intein chemistry[15] or by synthesis and ligation
of peptide fragments.[16–19] In this report, we present a fully
synthetic linear solid-phase peptide synthesis (SPPS)
[*] Dr. M. P. C. Mulder,[+] Dr. R. Merkx,[+] K. F. Witting, D. S. Hameed,
D. El Atmioui, L. Lelieveld, Prof. Dr. J. Neefjes, Dr. I. Berlin,
Prof. Dr. H. Ovaa
Division of Cell Biology, Netherlands Cancer Institute (NKI)




Dr. M. P. C. Mulder,[+] K. F. Witting, D. S. Hameed, D. El Atmioui,
Prof. Dr. J. Neefjes, Dr. I. Berlin, Prof. Dr. H. Ovaa
Oncode Institute and Department of Cell and Chemical Biology
Leiden University Medical Center (LUMC)
Einthovenweg 20, 2333 ZC Leiden (The Netherlands)
Dr. R. Merkx[+]
Current address: Medicines Evaluation Board
Graadt van Roggenweg 500, 3531 AH Utrecht (The Netherlands)
L. Lelieveld
Current address: Leiden Institute of Chemistry, Leiden University
Einsteinweg 55, 2300 RA Leiden (The Netherlands)
F. Liebelt, Dr. A. C. O. Vertegaal
Department of Cell and Chemical Biology
Leiden University Medical Center (LUMC)
Einthovenweg 20, 2333 ZC Leiden (The Netherlands)
[+] These authors contributed equally to this work.
Supporting information and the ORCID identification number(s) for
the author(s) of this article can be found under:
https://doi.org/10.1002/anie.201803483.
T 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co.
KGaA. This is an open access article under the terms of the Creative
Commons Attribution Non-Commercial License, which permits use,
distribution and reproduction in any medium, provided the original
work is properly cited, and is not used for commercial purposes.
Angewandte
ChemieCommunications
8958 T 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2018, 57, 8958 –8962
approach towards full-length SUMO conjugates, which ena-
bles facile parallel synthesis procedures. Since SUMO is
substantially larger than ubiquitin (SUMO-1 96 AA versus
ubiquitin 76 AA), it was considered to be beyond the limits of
linear SPPS. However, we explored the use of “aggregation
breakers” such as pseudoproline[20] and dimethoxybenzyl
(DMB)[21] residues at strategic positions and devised a syn-
thetic route that takes advantage of the specific building
blocks depicted in Figure 1A. This procedure allowed us to
make synthetic SUMO-1, -2, and -3 efficiently in a linear
fashion. Next, we used the linear SUMO synthesis to prepare
N-terminally fluorescently labelled SUMO-propargyl probes
(Figure 2) for monitoring SUMO-specific protease activities
in cell-based assays and visualizing their action in live cells by
fluorescence microscopy (Figures 3 and 4). Our parallel
methodology not only allowed us to make synthetic SUMO
and SUMO-based probes, but also enabled the synthesis of
a diSUMO covalent probe (Figure 2).
In approaching the challenge of a fully synthetic
approach, we identified two positions in the sequence of
SUMO-1 and five positions in the sequences of SUMO-2 and
-3 where dipeptide pseudoproline and DMB building blocks
could be incorporated (Figure 1A). Using conventional
Fmoc-based SPPS coupling conditions (4 equiv Fmoc pro-
tected amino acid, 4 equiv PyBOP, and 8 equiv DIPEA) and
double couplings, simultaneous incorporation of selected
building blocks led to successful synthesis of SUMO-1, -2, and
-3 in high purity. Correct folding of purified synthetic SUMO
proteins was verified by circular dichroism (CD) spectroscopy
(Figure 1B).
With a productive synthesis approach in hand, we
focussed on the generation of SUMO-based ABPs applicable
to profiling SUMO-specific proteases and visualizing proteo-
lytic activity in cells (Figure 2). For this purpose, we synthe-
sized SUMODG proteins on a hyper-acid-labile chlorotrityl
Figure 1. A) SUMO sequences and the position of the dipeptides
(pseudoprolines and dimethoxybenzyl) used during SUMO synthesis.
B) CD spectra of expressed SUMO proteins (Expr.) versus synthetic
SUMO proteins (FL). C) SDS-PAGE analysis of synthetic SUMO
polypeptides. M =marker, S1 = SUMO-1, S2 =SUMO-2, S3 =SUMO-3.
Figure 2. Design of the SUMO-propargyl and covalent diSUMO-2
activity-based probes for studying proteolytic cleavage, preference, and
selectivity by capturing active SENPs.
Figure 3. Activity-based profiling with SUMO ABPs. A) Labelling of
endogenous enzymes in HeLa cell lysates. Fluorescence scan and
immunoblot analyses for endogenous SENP1, SENP3, and USP7 are
shown; B) Labelling of ectopically expressed FLAG-SENPs 1–7 and
FLAG-USP15 (negative control) in HeLa cell lysates, visualized by
immunoblot. For fluorescence scans see Figure S3. C) Time-dependent
labelling of endogenous SENP3 and SENP1. For blots of other SENPs
see Figure S7. M = marker, S1 =Rho-SUMO-1-PA, S2 =Rho-SUMO-2-
PA, S3 =Rho-SUMO-3-PA, Ub =Rho-Ub-PA (negative control),
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resin (Scheme S1 in the Supporting Information) and func-
tionalized their N-termini with N,N’-Boc-protected 5-carbox-
yrhodamine.[22] Upon cleavage of the protected peptide from
the resin with hexafluoroisopropanol (HFIP), the propargy-
lamide (PA) electrophile[15, 23] was introduced by selective
coupling of propargylamine to the C-termini of SUMO using
standard coupling procedures. After global deprotection and
HPLC purification, the desired Rho-SUMO-PA probes were
obtained with an average overall yield of 10 %.
To validate reactivity and specificity of our SUMO-based
probes, purified catalytic domains of SENP1 and SENP6 were
incubated for 30 min at RT with Rho-SUMO-PA or Rho-Ub-
PA probes (Figure S2). SDS-PAGE analysis (Figure S2)
showed SENP1 reactivity toward probes of all three SUMO
isoforms, while SENP6 showed a clear preference for SUMO-
2/3, thus demonstrating the ability of these probes to
selectively react with active SENPs.
With a set of functional SUMO-based ABPs in hand, we
tested their binding for all known SUMO proteases in cell
lysates (Figure 3). Labelling of endogenous enzymes (Fig-
ure 3A) in HeLa cell lysates showed low expression of
endogenous SENP enzymes. Although reactivity for SENP1
and SENP3 could be visualized by immunoblotting (Fig-
ure 3A), we choose to transfect HeLa cells with plasmid
cDNAs for full-length, FLAG-tagged human SENP1-7 to
access the reactivity of the probes towards the full SENP
panel. Whole-cell lysates of transfected cells were incubated
with the Rho-SUMO-PA probes for 15 min at RT. Fluores-
cent scan and western blot analysis (Figures 3B and S3)
showed SUMO-bound SENP1 and SENP2 for all three
SUMO isoforms and a small preference of SENP6 for
SUMO-2/3 (longer exposure Figure S4), while SENP3 and
SENP7 showed a clear preference for SUMO-2/3 probes.
Next, we investigated whether we could generate
a diSUMO probe. Di-SUMO is known to be the natural
substrate for the two SUMO-chain-processing human SUMO
protease family members SENP6 and SENP7.[24] This new
type of reagent would allow us to study proteolytic cleavage
of SUMO chains.
In contrast to ubiquitin chains, where linkages through all
seven lysine residues have been observed, one type of SUMO
chain—linked through lysine 11 of SUMO-2/3—appears to
predominate.[4] Since SUMO-2/3 show a high degree of
sequence similarity, we chose to focus on a K11 diSUMO-2
vinylamide (VA) suicide version that can bind covalently. To
achieve this, we chemically mutated lysine K11 in the
proximal SUMO-2 to a diaminobutyric acid residue (Dab)
to preserve the length of the native isopeptide linkage. A
SUMO-2 K11Dab(Alloc) mutant (Scheme 1) was synthesized
using our linear Fmoc-based SPPS method, and subsequent
selective deprotection of the Dab(Alloc) residue was ach-
ieved through treatment with Pd(PPh3)4 and Ph3SiH, followed
by on-resin coupling of a previously reported ligation
handle.[25] Global deprotection and purification with HPLC
gave the desired proximal SUMO-2 K11 mutant. Then,
SUMO-2-DG-SEt thioester, corresponding to the distal part
of our probe design, was synthesized in a similar fashion by
Fmoc SPPS (see the Supporting Information). Native chem-
ical ligation of the (proximal) SUMO mutant and (distal)
SUMO-2-DG-SEt thioester was performed under denaturing
conditions in 6m Gdn·HCl, 0.15m sodium phosphate (pH 7.2)
with mercaptophenylacetic acid (MPAA, 250 mm) as a liga-
tion catalyst. Overnight incubation at 37 8C, monitored by
LC–MS, resulted in full consumption of the proximal SUMO
mutant and formation of the ligation product as an MPAA
disulfide. A short incubation with TCEP, followed by
preparative HPLC, afforded the K11 diSUMO-2 precursor.
Final thiol elimination of the warhead was achieved by
overnight incubation of the K11 diSUMO-2 precursor with
100 equiv of 2,5-dibromohexanediamide at 37 8C in 50 mm
sodium phosphate buffer (pH 8) to yield K11 diSUMO-2-
VA (Scheme 1, Figure S5).
To validate the reactivity of K11 diSUMO-2-VA, purified
catalytic domains of SENP1-8 were incubated for 1 h at 37 8C
with the K11 diSUMO-2 probe. As expected, SDS-PAGE
analysis showed diSUMO-reacted bands for all SENPs except
SENP8, which is reported to be a NEDD8-specific protease[26]
(Figure S6). Next, we tested the reactivity of the probe
towards known SUMO proteases in cell lysates. Both
endogenous and ectopically expressed SENPs readily and
specifically reacted with our mono- and di-SUMO ABPs, but
not with Ub-PA (Figure 3, Figure S3,S7) or mono-K11 g-
amino-VA-SUMO-2 control probes (Figure S8). Conversely,
the deubiquitinating enzymes (DUBs) USP7 and USP15,
both active against Ub-PA, displayed no reactivity against any
of the SUMO ABPs (Figure 3A and B). Interestingly, label-
ling of endogenous SENPs with our K11 diSUMO-2-VA
(Figures 3 C and S7) revealed for the first time that SENP3
possesses a preference for diSUMO-2. SUMO-2 chain-
processing capacity has been previously demonstrated for
SENP1,[27] SENP2, SENP6, and SENP7.[28] Unlike SENP1,
SENP3 appears to prefer diSUMO-2-VA to SUMO-1/2-PA
(Figure 3C and Figure S7), thus illustrating the potential of
diverse SUMO ABP reagents for comprehensively inter-
rogating the cellular machinery of SUMO deconjugation.
Scheme 1. Synthesis of K11 diSUMO-2-VA. Reagents and conditions:
a) Ph3SiH, Pd(PPh3)4, NMP; b) 4-((tert-butoxycarbonyl)amino)-3-(tert-
butyl disulfaneyl)butanoic acid, PyBOP, DIPEA, NMP; c) TFA/iPr3SiH/
phenol/H2O (90:2.5:2.5:5), 3 h, RT; d) 6m Gnd·HCl, 0.15 m sodium
phosphate buffer pH 7, 250 mm MPAA, SUMO2DGSEt, overnight;
e) 50 mm sodium phosphate buffer pH 8, 2,5-dibromohexanediamide,
37 8C, overnight. NMP =N-methylpyrrolidon, PyBOP= (benzotriazol-1-
yl-oxy)tripyrrolidinophosphonium hexafluorophosphate, DIPEA= di-iso-
propylethylamine, TFA = trifluoroacetic acid, Gnd=Guanidine.
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Subsequently, we used the fluorescent SUMO-PA
reagents to detect relevant enzymatic activities occurring
inside the cell. Fluorescent Rho-SUMO-2-PA, introduced
into HeLa cells by electroporation according to previously
devised methods,[29] was detected throughout the cell, but it
was concentrated in the nucleoplasm (N), nucleolus (NC),
and nuclear puncta (NP), likely corresponding to PML
bodies[30] (Figure 4A). To evaluate whether specific cellular
SENP activities could be visualized using this reagent, we
observed changes in the distribution of Rho-SUMO-2-PA in
response to ectopic overexpression of Flag-tagged SENP
enzymes (Figure 4B). Strikingly, in cells overexpressing Flag-
SENP2, Rho-SUMO-2-PA accumulated predominantly at
Flag-positive nuclear puncta (Figure 4B, top panels) and was
largely undetectable in either cytosol or nucleoli, thus
suggesting that the overexpressed Flag-SENP2 bound and
sequestered the probe. In agreement with gel-based activity
assays in Figure 3, the same observation was made for Rho-
SUMO-1-PA (Figure 4 B, middle panels). By contrast, in cells
overexpressing Flag-SENP7, Rho-SUMO-2-PA was distrib-
uted throughout the nucleoplasm (but not nucleoli), mirroring
the dispersed nuclear localization of this enzyme (Figure 4B,
bottom panels). Collectively, these experiments demonstrate
that the cellular distribution of our fluorescent SUMO probes
is responsive to modulation of cellular SENP activities and
can thus be used to interrogate SUMO protease activity in
cellular contexts.
Taken together, these experiments highlight a variety of
assays utilizing our SUMO ABPs for the interrogation of
SENP activities both in vitro and in their cellular context. The
straightforward nature of the experimental setups is expected
to make them readily adaptable to comparative profiling of
SUMO protease activity as a function of various biological or
chemical perturbations, such as starvation, infection, or
treatment with small-molecule inhibitors. The responsiveness
of our SUMO ABP tools to changes in SENP activities as
a result of heat shock[31] is illustrated in Figure S10.
In conclusion, we present a direct linear chemical syn-
thesis of SUMO proteins for the fast and scalable production
of mutants and conjugates with full control over the
incorporation of (unnatural) building blocks that enables
virtually unlimited structural modifications. In contrast to
extensive studies on ubiquitin chains, SUMO chains remain
relatively unexplored. The strategies presented here expand
the SUMO toolbox and open novel avenues for interrogation
of the SUMO-specific deconjugation machinery as well as
drug discovery efforts aimed at the development of SENP
inhibitors.[32]
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